Synthetic Farnesoid X Receptor Agonists Induce High-Density Lipoprotein-Mediated Transhepatic Cholesterol Efflux in Mice and Monkeys and Prevent Atherosclerosis in Cholesteryl Ester Transfer Protein Transgenic Low-Density Lipoprotein Receptor (−/−) Mice

Eva Hambruch(University Hospital Regensburg), Claus Kremoser(Phenex Pharmaceuticals (Germany)), Shinobu Miyazaki‐Anzai(University of Colorado Denver), Alfred Boettcher(University of Colorado Hospital), Makoto Miyazaki(Chiba Cancer Center), Michael Burnet(Synovo (Germany)), Ulrich Deuschle(Phenex Pharmaceuticals (Germany)), Helen Desiree Krol(University of Colorado Hospital), Sanja Perović‐Ottstadt(Johannes Gutenberg University Mainz), Silke Matysik(University of Colorado Hospital), Gerd Schmitz(University Hospital Regensburg), Ulrike K. Hahn(University of Colorado Hospital), Moshe Levi(Georgetown University), Thomas Schlüter(University of Colorado Hospital), Olaf Kinzel(University of Colorado Hospital)
Journal of Pharmacology and Experimental Therapeutics
August 24, 2012
Cited by 99


Related Papers